首页> 外文OA文献 >PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

【2h】

PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

机译：资源受限的PRM22微观模拟方法用于个性化医疗卫生政策决策

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jahn B.; Rochau U.; Mühlberger N.; Sroczynski G.; Conrads-Frank A.; Siebert U.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers [J] . Dj?ra I. Soeteman, Stephen C. Resch, Hawre Jalal, MDM Policy & Practice . 2020,第1期

机译：开发和验证婴幼儿艾滋病检测微观模型的形态学和卫生政策制定者决策支持工具的筛选策略
2. Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review [J] . Silva Monica Francisco, Ribeiro Claudia, Goncalves Virginia M. F., Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences . 2018,第5期

机译：甲氨蝶呤治疗药物的液相色谱方法作为个性化医学的临床决策支持：简要审查
3. Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype [J] . Laura H?rster, Richard F. Schlenk, Michael Stadler, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2017,第期

机译：个性化药物方法的成本效益。正常核型急性髓性白血病患者决策分析模型的结果
4. E-Health towards ecumenical framework for personalized medicine via Decision Support System [C] . Kouris Ioannis, Tsirmpas Charalampos, Mougiakakou Stavroula G., 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2010

机译：电子健康通过决策支持系统迈向个性化医学的普世框架
5. Effects of messages about genetics, race, and health on public opinion about personalized medicine and health policy. [D] . Landau, Jocelyn. 2009

机译：有关遗传学，种族和健康的信息对个性化医学和健康政策的公众舆论的影响。
6. A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582CT and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz [O] . Jonathan Evans, Marelize Swart, Nyarai Soko, -1

机译：资源受限的世界中针对个性化药物的全球健康诊断：用于CYP2B6基因分型的简单PCR-RFLP方法g.15582C T和抗逆转录病毒药物依非韦伦的最佳使用的科学和政策相关性
7. PHP85 WHEN AND HOW ARE EVIDENCE REVIEWS ON PERSONALIZED MEDICINE USED FOR HEALTH PLAN POLICY DECISIONS? [O] . Van Bebber SL, Trosman J, Phillips KA 2010

机译：PHP85何时以及如何对用于健康计划政策决定的个性化药物进行证据审查？

PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

著录项

引文网络

相似文献

相关主题

期刊订阅